The Chandos Clinic Limited 4674268 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is is osteopathy Digita Accounts Production Advanced 6.30.9574.0 true true 4674268 2024-04-01 2025-03-31 4674268 2025-03-31 4674268 core:CurrentFinancialInstruments 2025-03-31 4674268 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 4674268 core:FurnitureFittingsToolsEquipment 2025-03-31 4674268 core:LandBuildings 2025-03-31 4674268 core:OtherPropertyPlantEquipment 2025-03-31 4674268 bus:SmallEntities 2024-04-01 2025-03-31 4674268 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 4674268 bus:FilletedAccounts 2024-04-01 2025-03-31 4674268 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 4674268 bus:RegisteredOffice 2024-04-01 2025-03-31 4674268 bus:Director2 2024-04-01 2025-03-31 4674268 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 4674268 core:Buildings 2024-04-01 2025-03-31 4674268 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 4674268 core:LandBuildings 2024-04-01 2025-03-31 4674268 core:OfficeEquipment 2024-04-01 2025-03-31 4674268 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 4674268 countries:Wales 2024-04-01 2025-03-31 4674268 2024-03-31 4674268 core:FurnitureFittingsToolsEquipment 2024-03-31 4674268 core:LandBuildings 2024-03-31 4674268 core:OtherPropertyPlantEquipment 2024-03-31 4674268 2023-04-01 2024-03-31 4674268 2024-03-31 4674268 core:CurrentFinancialInstruments 2024-03-31 4674268 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 4674268 core:FurnitureFittingsToolsEquipment 2024-03-31 4674268 core:LandBuildings 2024-03-31 4674268 core:OtherPropertyPlantEquipment 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 4674268

The Chandos Clinic Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

The Chandos Clinic Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

The Chandos Clinic Limited

Company Information

Director

Mr GJ Cleghorn

Registered office

21 Chandos Road
Redland
Bristol
BS6 6PG

Accountants

Janet Essex
Chartered Accountants
Saville Court
11 Saville Place
Clifton
Bristol
BS8 4EJ

 

The Chandos Clinic Limited

(Registration number: 4674268)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

4,052

5,701

Current assets

 

Debtors

6

17,045

4,815

Cash at bank and in hand

 

49,874

136,095

 

66,919

140,910

Creditors: Amounts falling due within one year

7

(2,559)

(25,310)

Net current assets

 

64,360

115,600

Total assets less current liabilities

 

68,412

121,301

Provisions for liabilities

-

(1,083)

Net assets

 

68,412

120,218

Capital and reserves

 

Called up share capital

8

100

100

Retained earnings

68,312

120,118

Shareholders' funds

 

68,412

120,218

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 14 October 2025
 

.........................................
Mr GJ Cleghorn
Director

 

The Chandos Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in Wales.

The address of its registered office is:
21 Chandos Road
Redland
Bristol
BS6 6PG

These financial statements were authorised for issue by the director on 14 October 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

The Chandos Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Premises improvements

straight line - 10%

Computer equipment

reducing balance - 33%

Fixtures and fittings

reducing balance - 15%

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

The Chandos Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 4 (2024 - 4).

 

The Chandos Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 April 2024

4,063

38,042

18,380

60,485

At 31 March 2025

4,063

38,042

18,380

60,485

Depreciation

At 1 April 2024

4,063

32,341

18,380

54,784

Charge for the year

-

1,649

-

1,649

At 31 March 2025

4,063

33,990

18,380

56,433

Carrying amount

At 31 March 2025

-

4,052

-

4,052

At 31 March 2024

-

5,701

-

5,701

Included within the net book value of land and buildings above is £Nil (2024 - £Nil) in respect of freehold land and buildings.
 

5

Stocks

2025
£

2024
£

6

Debtors

Current

2025
£

2024
£

Trade debtors

3,326

4,815

Other debtors

13,719

-

 

17,045

4,815

 

The Chandos Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

7

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Taxation and social security

-

22,292

Other creditors

2,559

3,018

2,559

25,310

8

Share capital

9

Dividends

Final dividends paid

2025
£

2024
£

Final dividend of Nil per each

-

-

 

 

10

Related party transactions

 

The Chandos Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Director's remuneration

The director's remuneration for the year was as follows:

2025
£

2024
£

Remuneration

12,778

12,778

Contributions paid to money purchase schemes

80,000

196

92,778

12,974